Bariatric metabolic surgery is associated with a lower risk for heart failure versus GLP-1RAs

In an observational cohort study of adults living with obesity and diabetes, we found that the primary incidence of congestive heart failure was lower in patients treated with bariatric metabolic surgery than in those on first-generation GLP-1 receptor agonists, an effect that was not explained by greater weight loss in the group that received bariatric metabolic surgery.